A Biomarker of Type VI Collagen Degradation (C6M) Is Associated with Changes in ASDAS MRI Measures of Inflammation in Patients with Axial Spondyloarthritis During TNF Inhibitor Therapy

Signe Holm Nielsen*, Anne Bay-Jensen, Mikkel Østergaard, Anne Siebuhr, Morten Karsdal, Inge Juul Sørensen, Ulrich Weber, Anne Gitte Loft, Gina Kollerup, Gorm Thamsborg, Ole Rintek Madsen, Jakob Møller, Susanne Juhl Pedersen

*Corresponding author for this work

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number0583
JournalArthritis and Rheumatology
Volume71
Issue numberS10
Number of pages3
ISSN2326-5205
DOIs
Publication statusPublished - 2019
Event2019 ACR/ARP Annual Meeting - Atlanta, United States
Duration: 8 Nov 201913 Nov 2019

Conference

Conference2019 ACR/ARP Annual Meeting
CountryUnited States
CityAtlanta
Period08/11/201913/11/2019

Cite this

Nielsen, S. H., Bay-Jensen, A., Østergaard, M., Siebuhr, A., Karsdal, M., Sørensen, I. J., Weber, U., Loft, A. G., Kollerup, G., Thamsborg, G., Madsen, O. R., Møller, J., & Pedersen, S. J. (2019). A Biomarker of Type VI Collagen Degradation (C6M) Is Associated with Changes in ASDAS MRI Measures of Inflammation in Patients with Axial Spondyloarthritis During TNF Inhibitor Therapy. Arthritis and Rheumatology, 71(S10), [0583]. https://doi.org/10.1002/art.41108